Alteogen, Stock Price Down 2.46% at This Time... Institutional Investors Net Buy 24,412 Shares in Last 5 Days

Alteogen is trading at 277,200 KRW as of 12:31 PM on the 25th, down 2.46% from the previous day. The trading volume is 1,249,361 shares, which is 45.61% of the previous day's volume. Alteogen is known as a biosimilar developer.

On June 25, Lee Dong-geon, a researcher at Shinhan Financial Investment, stated, "A large-scale license agreement worth 4.7 trillion KRW was signed with a global top 10 pharmaceutical company. This contract covers a total of six targets, with a structure to receive up to 776.3 billion KRW in milestones and royalties per target. Attention is drawn to the scalability of the company that signed the largest platform license agreement in Korea. In other words, the commercialization potential is higher compared to new drugs, and since only clinical phases 1 and 3 are conducted, the required time is significantly shorter." He set Alteogen's target price at 340,000 KRW.

Over the past five days, individual investors have net sold 6,266 shares of Alteogen, while foreigners and institutions have net sold 1,761 shares and net bought 24,412 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.